Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China · Delayed Price · Currency is CNY 27.14
+0.11 (0.41%)
Apr 30, 2026, 3:00 PM CST
SHA:603351 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 150.03 | 148.99 | 146.42 | 112.2 | 95.03 | 101.37 |
Depreciation & Amortization | 132.72 | 132.72 | 115.49 | 71.74 | 71.76 | 42.81 |
Other Amortization | 0.25 | 0.25 | 0.66 | 1.03 | 1.1 | 1.13 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | - | - | 0 | 0.05 |
Asset Writedown & Restructuring Costs | 3.04 | 3.04 | 0.17 | 0.18 | 0.1 | 1.91 |
Loss (Gain) From Sale of Investments | -0.02 | -0.02 | -12 | -1.44 | 0.11 | -2.25 |
Provision & Write-off of Bad Debts | - | - | 0.34 | 0.29 | -4.48 | 2.35 |
Other Operating Activities | 5.81 | 11.87 | 20.28 | 14.26 | 12.21 | 6.17 |
Change in Accounts Receivable | -414.81 | -414.81 | -13.57 | -31.41 | 34.17 | -105.72 |
Change in Inventory | -10.12 | -10.12 | -40.46 | -9.38 | -22.77 | -29.18 |
Change in Accounts Payable | 365.19 | 365.19 | -3.98 | -43.96 | -106.45 | -42.06 |
Change in Other Net Operating Assets | -2.43 | -2.43 | 3.36 | 10.46 | 28.06 | 15.44 |
Operating Cash Flow | 233.23 | 238.24 | 221.79 | 120.24 | 108.99 | -11.54 |
Operating Cash Flow Growth | 8.77% | 7.42% | 84.45% | 10.33% | - | - |
Capital Expenditures | -46.38 | -52.18 | -51.46 | -73.07 | -233.9 | -235.62 |
Sale of Property, Plant & Equipment | 0.22 | 0.22 | - | - | - | - |
Investment in Securities | 2.88 | -22.12 | -18.53 | 5.23 | -4.73 | 172.72 |
Other Investing Activities | -0.18 | 0.02 | -0.5 | - | 0.95 | -5.07 |
Investing Cash Flow | -43.46 | -74.06 | -70.48 | -67.84 | -237.68 | -67.97 |
Long-Term Debt Issued | - | 551 | 381.02 | 483.15 | 480.87 | 220.06 |
Total Debt Issued | 630 | 551 | 381.02 | 483.15 | 480.87 | 220.06 |
Long-Term Debt Repaid | - | -461.32 | -387.19 | -434.1 | -268.19 | -157.47 |
Total Debt Repaid | -551.02 | -461.32 | -387.19 | -434.1 | -268.19 | -157.47 |
Net Debt Issued (Repaid) | 78.98 | 89.68 | -6.16 | 49.05 | 212.68 | 62.59 |
Issuance of Common Stock | - | - | - | - | - | 49.27 |
Common Dividends Paid | -65.61 | -64.89 | -55.47 | -53.41 | -53.89 | -45.25 |
Other Financing Activities | -10.38 | -11.49 | -1.4 | 9.16 | 2.4 | 3.95 |
Financing Cash Flow | 2.99 | 13.3 | -63.03 | 4.79 | 161.2 | 70.56 |
Foreign Exchange Rate Adjustments | -2.69 | -0.83 | 1.37 | 0.53 | 1.06 | -0.36 |
Net Cash Flow | 190.07 | 176.66 | 89.65 | 57.72 | 33.56 | -9.3 |
Free Cash Flow | 186.85 | 186.07 | 170.34 | 47.17 | -124.91 | -247.16 |
Free Cash Flow Growth | 19.03% | 9.23% | 261.09% | - | - | - |
Free Cash Flow Margin | 13.93% | 13.94% | 13.14% | 4.08% | -11.24% | -23.71% |
Free Cash Flow Per Share | 1.38 | 1.37 | 1.26 | 0.35 | -0.93 | -1.85 |
Cash Income Tax Paid | 70.12 | 66.66 | 70.09 | 52.21 | -2.99 | 25.21 |
Levered Free Cash Flow | 202.2 | 211.27 | 122.94 | -23.51 | -90.86 | -214.39 |
Unlevered Free Cash Flow | 202.2 | 211.27 | 131.58 | -13.98 | -83.05 | -209.99 |
Change in Working Capital | -58.58 | -58.58 | -49.56 | -78.01 | -66.84 | -165.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.